The potential impact of the impending U.S. Presidential election on prescription drug pricing and marketing practices has become a source for heated debate among many key legislators and pharmaceutical executives. On September 27-29 in Philadelphia, The Pharmaceutical Marketing Congress (PMC), will convene some of the industry’s most influential decision-makers in an expert panel that will debate and provide insight on issues including the recent rise in drug importation, parallel importation, pricing and the passage of Medicare Prescription Drug legislation.
